Responses

Dear Gloucestershire Health and Care NHS Foundation Trust,

I would appreciate your input on the following questions

1. Service Context & Care Pathway

• Does your Trust diagnose and/or treat patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?

Our response:

You asked:

• If yes, which clinical departments or specialties are responsible for CIDP diagnosis and management?
(e.g., Neurology, Neurophysiology, Immunology, Specialist Neuromuscular Services)
• Does your Trust operate a specialist neuromuscular or neuroimmunology service?
If so, please provide a brief description (e.g., staffing, catchment area, referral pathways).

2. CIDP Patient Numbers
• How many patients with a confirmed diagnosis of CIDP are currently recorded within your Trust?
Please provide the most recent 12 month period available.
• If available, please provide the number of newly diagnosed CIDP patients in the same period.
• If diagnosis data are coded, please confirm which coding system is used (e.g., ICD 10, SNOMED CT).

3. CIDP Treatment With IVIg
• How many CIDP patients received intravenous immunoglobulin (IVIg) at your Trust in the most recent 12 month period?
• Please provide the number of IVIg treatment episodes administered to CIDP patients in that period.
• If available, please provide the total volume (grams) of IVIg used for CIDP during the same period.
• How many CIDP patients received IVIg vs SCIg in the most recent 12‑month period?
• If SCIg is used, please provide the number of treatment episodes and total grams administered.
• If available, please provide typical dosing regimens used for CIDP (e.g., grams/kg and treatment intervals).
• If recorded, please provide the average number of IVIg cycles per CIDP patient per year.

4. Operational & Capacity Information
• Does your Trust have a formal protocol or clinical guideline for the diagnosis and management of CIDP?
If yes, please provide a copy or link.
• Does your Trust operate a waiting list for IVIg treatment?
If yes, please provide the current number of patients waiting and the average waiting time.
• Does your Trust participate in any regional or national neuromuscular networks relevant to CIDP?
• Does your Trust record adverse events or complications associated with IVIg administration in CIDP patients? If yes, please provide any available summary data.

5. Commissioning, Governance & Funding
• Which commissioning arrangements apply to CIDP treatment at your Trust?
(e.g., specialised commissioning, local ICB commissioning)
• Does your Trust use a prior approval or funding request process for IVIg in CIDP?
• Does your Trust participate in the National Immunoglobulin Database (NID)? If yes, do you routinely submit CIDP specific data?

Thank you in advance
Yours faithfully,

Electro Convulsive Treatment/Restraints/Seclusion/Medicated Errors

Copy of Trust Policy, MH Services

Hello
Hope you are good + thank you for all you do …
Please could you answer the following questions under the freedom of information act ….
If you would like to split the request into 4 parts – please do so …
I am dyslexic – so please provide the data in email text – which is one of my preferred formats
Hope we have a good week
In love + solidarity

Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: –
1.Please supply patient’s information ECT leaflet
2.Please supply patient ECT consent form
3.Please supply any ECT reports/investigations
4.How many ECT in 2025?
5.What proportion of patients were men/women?
6.How old were they?
7.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
8.How many people covered by the equality act – specific protected characteristics – excluding age + gender – received ECT ?
9.How many people were offered talking therapy prior to ECT ?
10.How many were receiving ECT for the first time?
11.How many patients consented to ECT?
12.How many ECT complaints were investigated outside the NHS ?
13.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?
14.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?
15.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?
16.How many patients have suffered complications during and after ECT and what were those complications?
17.Have there been any formal complaints from patients/relatives about ECT?
18.If so, what was their concerns?
19.How many patients report memory loss/loss of cognitive function?
20.What tests are used to assess memory loss/loss of cognitive function?
21.Have MRI or CT scans been used before and after ECT?
22.If so, what was the conclusion?
23.How does the Trust plan to prevent ECT in the future?

Please provide restraints information under the FOI act to the following questions: –
1.Please supply any Restraints/investigations
2.How many RESTRAINTS in 2025?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act – specific protected characteristics – excluding age + gender – were restrainted?
7.How many RESTRAINTS were investigated outside the NHS?
8.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
9.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?
11.How many patients have suffered complications during and after RESTRAINTS and what were those complications?
12.Have there been any formal complaints from patients/relatives about RESTRAINTS?
13.If so, what was their concerns?
14.Are counts of forced injections available? if so how many people were forcible injected ?
15.How does the Trust plan to reduce restraints in the future?
16.How many of these restraints were face down restraints?

Please provide SECLUSION information under the FOI act to the following questions: –
1.Please supply any SECLUSION reports/investigations
2.How many SECLUSIONS in 2025?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act – specific protected characteristics – excluding age + gender – were secluded ?
7.How many SECLUSIONS were investigated outside the NHS?
8.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
9.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
10.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?
11.How many patients have suffered complications during and after SECLUSION and what were those complications?
12.Have there been any formal complaints from patients/relatives about SECLUSION?
13.If so, what was their concerns?
14.How does the Trust plan to reduce SECLUSIONS in the future?

Please provide MEDICATION ERRORS information under the FOI act to the following questions: –
1.Please supply any MEDICATION ERRORS reports/investigations
2.How many MEDICATION ERRORS in 2025?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act – specific protected characteristics – excluding age + gender – endured medication errors ?
7.How many MEDICATION ERRORS were investigated outside the NHS ?
8.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
9.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?
11.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?
12.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?
13.If so, what was their concerns?
14.How does the Trust plan to prevent MEDICATION ERRORS in the future?

Seclusion Practices

To whomever this concerns,

I’m an MSc student studying Clinical and Health Psychology at the University of Manchester.

I’m currently conducting a research project as part of my degree, where I am exploring seclusion practices in the NHS.

The data from this request would be used as part of my analysis, and, therefore, would be greatly appreciated.

Please could you send me all the trust policies related to seclusion practices?

For example: in what circumstances these practices should be used; how they should be used; staff training; any guidance on ensuring practice is trauma-informed; and how the process is monitored or reviewed.

I would like to make it clear that this request is not for any individualised patient data.

Please be assured that your Trust’s name will be anonymised as part of my analysis.

Kind regards,

Omega-3 supplementation in pregnancy: a survey of UK practice

Freedom of Information Request – Ref: FOI 161-2026 Thank you for your recent Freedom of...

Dermatology Services

ESR/Workforce, Nursing & Agency Nursing

Dear FOI team,

I am writing to you under the Freedom of Information Act 2000 to request the following information from your Trust. The questions relate to dermatology services your Trust commissions, including the use of teledermatology. Please could you provide me with answers to the following:

1. Teledermatology provision

Does your organisation currently use a teledermatology platform or system to support the delivery of dermatology services? If yes, please confirm whether this is used for any of the following purposes:
• Store-and-forward image review
• Advice and Guidance between primary and secondary care
• Remote consultation or virtual outpatient appointments
• Triage of urgent suspected skin cancer referrals

2. Technology platform
Please state the name of the teledermatology software platform or system currently in use. If more than one platform is in use, please list all and indicate the purpose of each.

3. Commissioning and funding arrangements

Is the teledermatology platform funded and procured directly by your organisation, or is it commissioned and funded by your ICB? If both apply, please clarify which platforms fall under each arrangement. Additionally, please indicate whether any of your teledermatology platforms are funded centrally, for example through research-supported or NHS England funding.

4. Contract details

Please state the start date, end date, and total contract value of the current teledermatology platform contract or contracts, where this information is not exempt from disclosure.

5. Procurement plans

Is there an active or planned procurement for a teledermatology platform currently under way or anticipated within the next 24 months? If yes, please provide details of the anticipated timeline.

6. Dermatology referral activity

For the most recent full financial year for which data is available, please provide:
• The total number of new referrals onto a dermatology Referral to Treatment (RTT) pathway received by your organisation
• The total number of urgent suspected cancer (two-week wait) referrals for skin cancer received by your organisation
• The total number of skin cancers diagnosed by your organisation

7. Key contacts

Please provide the name and contact details, or job title if personal details are not disclosable, of the following individuals within your organisation:
• The clinical lead for dermatology
• The operational or service lead responsible for dermatology services
• The individual responsible for digital or technology procurement within dermatology or the wider clinical directorate

Best wishes,

Locum Doctors

Good Morning,

Please can I request the below information:

In the period 1st February 2026 to 30th April 2026 please provide a breakdown of:
• Total trust spend with framework agencies for locum doctors
Please provide a further breakdown for locum doctors by:
• Spend per grade
• Spend per specialty
• Spend per agency name
 
In the period 1st February 2026 to 30th April 2026 please provide a breakdown of:
• Total trust spend with off-framework agencies for locums doctors
Please provide a further breakdown for locum doctors by:
• Spend per grade
• Spend per specialty
• Spend per agency name
 
In the period 1st February 2026 to 30th April 2026 please provide a breakdown of:
• Total trust spend with the internal trust bank or associated external provider for locum doctors
Please provide a further breakdown for locum doctors by:
• Spend per grade
• Spend per specialty
• Spend per internal or associated external provider

Please confirm your allocated budget for agency locum doctors for the period 1st February 2026 to 30th April 2026

Please confirm the name of the framework used for the supply of locum doctors in your trust.

Thanks in advance

Locum Doctor Hourly Rates

ESR/Workforce

Dear Sir/Madam,

Reference: FOI-LR-2026-057

I am writing to make a request under the Freedom of Information Act 2000 for information relating to locum doctor hourly pay rates at Gloucestershire Health and Care NHS Foundation Trust.

Please provide the Trust’s current standard locum doctor hourly rates for the financial year 2025/26, or the most recent rates currently in effect if no 2025/26 rates are held.

For the purposes of this request, I am seeking the Trust’s standard internal bank, staff bank, NHS Professionals, collaborative bank, or equivalent Trust locum rate card or schedule of rates. If rates vary by hospital site, specialty, department, or escalation status, please provide the standard default rate and indicate where variation applies. I am not seeking individual payroll records or personal data.

To reduce administrative burden, I am not asking the Trust to create new calculations or undertake analysis; I am requesting the recorded rate card, schedule, policy, or closest held information from which these rates are normally applied.

Please provide the rates for the following grade levels, where applicable:
– FY1 / Foundation Year 1
– FY2 / Foundation Year 2
– ST1-2 / CT1-2 / equivalent SHO-level grade
– ST3-5 / equivalent registrar-level grade
– ST6-8 / senior registrar-level grade

For each grade, please provide the hourly rate in GBP and the time window during which the rate applies for each of the following shift
categories:
1. Weekday day
2. Weekday evening
3. Weekday night
4. Weekend day
5. Weekend evening
6. Weekend night

Where possible, I would be grateful if the information could be provided in the following column structure:

For example:

Gloucestershire Health and Care NHS Foundation Trust | FY2 | Weekday night | £X.XX | 21:00-09:00 | Standard internal bank rate

If the Trust uses a rate card, spreadsheet, policy document, or schedule of rates containing the equivalent information, I would be happy to receive that document as an attachment instead.

If any grade level or shift category is not used by the Trust, please indicate this as “not applicable” or “not held”, as appropriate.

If the requested information is not held in this exact format, please provide the closest recorded information held by the Trust. If any part of the request is unclear or likely to exceed the appropriate cost limit, please provide advice and assistance under section 16 of the Act as to how the request may be refined.

Please quote the reference FOI-LR-2026-057 in your response where possible.

Keyboard Jamming

Dear Sir or Madam

I am writing to request information under the Freedom of Information Act 2000. Dating from January 1, 2020, I was hoping to find out:

The number of staff members employed by the Trust who were dismissed following disciplinary action where the alleged misconduct involved the use of so-called “keyboard jamming” or similar methods intended to simulate activity while working from home A breakdown of the number of these dismissals by year.

I am happy to receive the answer via email.

Neurodiversity Services (ADHD and ASD)

Dear FOI Team, I am investigating NHS-commissioned Neurodiversity Services (ADHD and ASD) across the UK. “Neurodiversity Services” here includes assessment, medication initiation / titration and post-diagnostic support to individuals in the community. In England, this includes provision delivered via Right to Choose / Any Qualified Provider arrangements, where applicable. Under the Freedom of Information Act 2000, I would like to request the following information: 1. Please provide your total annual spend (for each of the last three financial years, FY23/24, FY24/25, FY25/FY26) on ADHD and Autism assessments, broken down by: a. Total annual spend by third party private provider* b. For each third party private provider, total annual spend by assessment type (ADHD / Autism) 2. Please provide your total number of patients (for each of the last three financial years, FY23/24, FY24/25, FY25/FY26) on ADHD and Autism assessments, broken down by: a. Total number of patients assessed by third party private provider* b. For each third party private provider, total number of patients assessed by assessment type (ADHD / Autism) 3. For each third party private provider, please indicate the contract type (block / activity-based), start date and end date Please include volumes from NHS Trusts within your ICB that may deliver these services, and also third party private providers (or indicate if this is not possible) FY is defined as a year starting in April and ending in March. For example, FY23/24 starts on 1 April 2023 and ends on 31 March 2024. If exact spend by provider is not disclosable, please provide spend in bands (e.g., £5m) or top 5 providers plus ‘all others’ *Third-party private providers Refers to independent, non-NHS organisations contracted to deliver ADHD and / or Autism services. These providers operate outside of NHS Trusts / ICBs / Health Boards and typically deliver services such as assessments, prescribing, post-diagnostic support, and therapy. Examples may include (but are not limited to) ADHD 360, Psychiatry UK, Clinical Partners, and Evolve Psychology. These providers may deliver services under direct contracts with the ICB, via framework agreements, or under the NHS Right to Choose pathway. Best regards, Rosie Seel

Ventilator Asset Register

Dear FOI Officer,
Under the Freedom of Information Act 2000, I would like to request access to existing recorded information held by Gloucestershire Hospitals NHS Foundation Trust relating to life support ventilators (ICU, HDU, Non Invasive Ventilation, and JET ventilators).
Please provide an extract from the Trust’s current equipment or asset register showing all ventilators in use across the Trust’s sites, including:
• Gloucestershire Royal Hospital
• Cheltenham General Hospital
• Any associated community or satellite sites
For each ventilator, please include:
1. Ventilator Details
• Manufacturer
• Model
• Year of purchase (If the purchase year is not recorded, please provide the installation year instead.)
2. Replacement / Upgrade Plans
• If held, confirmation of whether ventilator replacement or upgrade is recorded as planned within the next 24 months (Yes/No only – no further detail required.)
3. Format
If the information is already held within a single document or register, please provide that document.
If any part of this request is unclear or is likely to exceed the appropriate cost limit, please let me know how it may be refined.
Please provide the information in electronic format if possible.
Thank you for your assistance.

Kind Regards

Cybersecurity

Dear FOI Team,

This is a request under the Freedom of Information Act 2000 regarding cybersecurity, cyber resilience and EHR/EPR supplier compliance. Please answer the questions below; where information is not held, please confirm this.

1. Certifications and DSPT status (please tick / fill)

Item Trust EHR/EPR Supplier
ISO 27001 — valid certification held? (Y/N)
ISO 22301 — valid certification held? (Y/N)
Cyber Essentials Plus — valid certificate held? (Y/N)
DSPT — submission completed for most recent assessment year? (Y/N)
DSPT — published status (Exceeded / Met / Approaching / Not Met)
DSPT — independent audit of submission undertaken? (Y/N) [supplier only] N/A

2. DSPT — narrative follow-up
If any DSPT requirements were recorded as ‘Not Met’ or ‘Approaching Standards’ in your most recent submission (Trust or supplier), please briefly describe the areas affected and confirm whether an improvement plan was submitted to NHS England.

3. Clinical safety
a. Has the Trust produced a DCB0160-compliant Deployment Safety Case and Hazard Log for its primary EHR/EPR system?
b. Has the EHR/EPR supplier produced a DCB0129-compliant Clinical Safety Case Report and Hazard Log?
c. Please name the Clinical Safety Officer (CSO) for (i) the Trust and (ii) the EHR/EPR supplier.
d. Has the Trust conducted simulation exercises or downtime training with clinical staff to prepare for a ransomware attack?

4. Cybersecurity leadership and staffing
a. Does the Trust have dedicated cybersecurity staff (separate from general IT)? If yes, please give the FTE count.
b. Does the EHR/EPR supplier have a Chief Information Security Officer (CISO), and is this role UK-based?
c. Does the supplier have UK-based cybersecurity staff responsible for NHS-deployed systems? If yes, please give the FTE count.

Please identify your primary EHR/EPR supplier when answering the supplier-related items above.

Thank you for your assistance.

Kind regards,

Digital/IT Contact Points and Roles

IT, Staffing

Dear Sir/Madam,

I am writing to make a request under the Freedom of Information Act 2000.

I would be grateful if you could provide the following information:

1. Contact details for relevant departments within the Trust, particularly those relating to Digital, IT, Clinical Informatics, or Innovation (e.g. shared or generic email inboxes and main telephone numbers).

2. Any role-based or shared contact details (e.g. group email addresses) used for senior leadership functions within these areas (for example, CIO office, CCIO function, Digital Directorate, or equivalent), where such contact points exist.

3. A list of senior roles within the Trust responsible for Digital and Clinical Informatics functions, including job titles only (for example: CIO, CCIO, CNIO, Director of Digital, Head of IT), without personal names.

Where available, any published organisational charts or structural information relating to these teams.

Please note that I am not requesting personal data relating to identifiable individuals (such as direct email addresses or phone numbers for named staff), and I am content for any such information to be withheld under Section 40 where applicable.

If this request exceeds the appropriate cost limit, I would be grateful if you could advise how it may be refined.

I look forward to your response within the statutory timeframe of 20 working days.

Kind regards,

IT Infrastructure

Dear FOI Team,

I am writing to make a request under the Freedom of Information Act 2000 for the following information relating to your Trust’s IT infrastructure:

1. A list of server hardware currently in use, including manufacturer, model, and year of installation or purchase.
2. A list of storage hardware (SAN/NAS) currently in use, including manufacturer, model, and year of installation or purchase.
3. A list of networking equipment (switches, routers, firewalls, load balancers) currently in use, including manufacturer, model, and year of installation or purchase.
4. For each item above, whether the equipment is currently covered by the original manufacturer’s support/warranty, a third-party maintenance provider, or is unsupported.
5. The annual spend on hardware maintenance and support contracts for the categories listed above, for the most recent financial year.
6. The date(s) on which current hardware maintenance contracts are due for renewal.
7. The name, job title, and contact email address of the person(s) responsible for IT infrastructure procurement and/or hardware maintenance contracts.

If it is not possible to provide all of the above, I would welcome any partial response covering the information that is readily available. I am happy to narrow the scope of this request if needed please contact me to discuss.

I would prefer the information in electronic format (spreadsheet or PDF).

Thank you for your assistance.

Yours faithfully,

Leaseholder of Buildings

Dear Gloucestershire Health and Care NHS Trust

I am writing a government paper and as part of the freedom of information act, please can I kindly request a list of any properties whereby the trust are the Leaseholders of the building in the last 5 years.

I look forward to hearing from you.

Kind regards

NHS Owned Clinical Facilities

Clinical Activity Data, Health, MH Services

Dear Sir or Madam,

I am writing to request information under the Freedom of Information Act 2000.

Please provide details of any hospitals, community hospitals, medical centres, minor injury units, outpatient departments, or NHS-owned clinical facilities within Gloucestershire that are:

a) Planned for closure,
b) Proposed for closure,
c) Under review, consolidation, or consideration for service withdrawal, where such changes are anticipated, scheduled, or being considered during the 2026 calendar year.

For each site identified, please provide:

1. The name and address of the facility
2. The services affected
3. The current status of the proposal (e.g. under review, consultation, approved)
4. Any indicative or proposed timescale. In addition, please provide copies of, or links to, any estates strategies, service reconfiguration plans, or financial recovery plans produced since 1 January 2024 that reference potential closures or service withdrawals during 2026

If no such sites exist, please confirm this explicitly.

If the request exceeds the cost limit, I would appreciate advice under Section 16 of the Act to refine the scope.

Yours faithfully,

Sick Days Taken by Junior Doctors

ESR/Workforce

Monday 27th April 2026

RE: Request under the Freedom of Information Act (2000)

Dear Information Team

This is an information request regarding sick days taken by resident (junior) doctors.

Please include the following information for the following years 2022/23, 2023/24, 2024/25, 2025/26

• Total number of sick days taken by resident doctors

• Total number of resident doctors that took sick days

• Total number of sick days taken by resident doctors for mental health reasons

• Total number of resident doctors that took sick days due to mental health

If this is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.

If you have any queries please don’t hesitate to contact me via email or phone and I will be very happy to clarify what I am asking for.

I would prefer a response via email, but if not possible, I will gladly accept letters to the address below.

Please acknowledge this information request as soon as possible.

Kind regards,

Young Onset Dementia

Dear Sir/Madam,
I am writing to request information under the Freedom of Information Act 2000 regarding individuals with young onset dementia (defined as individuals of any age who first experienced symptoms of dementia under the age of 65 and then received a formal diagnosis) within your local authority area.
Please provide the following information, using the most recent available data (preferably as of 14 April 2026 where possible).
Where data specific to young onset dementia as defined above is not held, please provide the closest available proxy (for example, individuals under 65 with a dementia diagnosis and note the proxy that has been used).
Questions
• The number of individuals who were diagnosed with dementia under the age of 65 currently under the care of your services.
• The number of individuals under the age of 65 diagnosed with dementia within the most recent 12 months of validated data.
• The number of individuals who were under the age of 65 when diagnosed with dementia who were detained under the Mental Health Act in the last 12 months (if recorded).
• The number of individuals who were diagnosed with dementia under the age of 65 currently receiving Section 117 aftercare (if recorded).
• The number of individuals who were diagnosed with dementia under the age of 65 currently:
o Receiving community-based support
o Admitted to inpatient mental health settings
• The number of individuals under the age of 65 with dementia who have experienced a delayed discharge from inpatient settings in the last 12 months (if recorded).
• Does your organisation routinely record young onset dementia as a distinct category within its data systems? (Yes/No)
If the requested information is not held in the exact format above, please provide the closest available data.
If any part of this request exceeds cost limits, please provide advice and assistance to refine the request.

Please let me know if you have any questions.
Kind regards,

Impact of April 2025 Visa Salary Threshold Changes on Lower-Paid Staff

HR, Staffing

Freedom of Information request – impact of April 2025 visa salary threshold changes on Band 3 and lower-paid staff

Dear Freedom of Information Team,

Please treat this as a request for information under the Freedom of Information Act 2000.

I am requesting information relating to the impact of the April 2025 visa salary threshold changes on lower-paid NHS staff, particularly Band 3 and below roles.

For the purposes of this request, please provide information covering the period: 9 April 2025 to 31 March 2026

If it is easier for the Trust to provide information for a slightly different date range already used in internal reporting, please do so and indicate the period covered.

1) Employees requiring visas in Band 3 and below Please provide the number of employees at Band 3 and below who, during the period above, required a visa in order to work for the Trust. Please break this down by: pay band job title / role visa type, where recorded (for example: Skilled Worker visa, Graduate visa, Dependant visa, Health and Care Worker visa, or other) If visa type is not centrally recorded, please state this.

2) Staff whose employment ended or changed where visa status was a contributing factor Please provide the number of employees whose employment ended or whose role changed during the period above where visa status, visa expiry, or visa-renewal ineligibility was a contributing factor. Please include the following categories, if held: formal dismissals non-renewal of fixed-term contracts resignations linked to visa-related issues staff who left employment before visa expiry due to anticipated ineligibility redeployments or transfers to different roles due to visa/salary issues cases where sponsorship was not offered or not renewed Please break this down by: pay band job title / role reason category

3) Staff in roles below the relevant visa salary threshold Please provide the number of employees who, at any point during the period above: required visa sponsorship (or would require sponsorship upon expiry of their current visa in order to remain employed), and were employed in roles whose salary was below the relevant visa salary threshold applicable to them at that time. Please break this down by: pay band job title / role If the Trust does not hold this as a single dataset, please provide any equivalent recorded information, internal reports, or assessments used to identify staff potentially affected.

4) Sponsorship decisions and Certificates of Sponsorship Please provide the following information for the period above: a) The number of Certificates of Sponsorship (CoS) issued by the Trust, broken down by: pay band job title / role b) The number of cases where sponsorship was: not offered not renewed withdrawn determined not to be viable where the salary for the role did not meet the applicable visa salary threshold. Please break this down by: pay band job title / role

5) Policies, guidance, and mitigation measures Please provide copies of any policies, guidance, internal instructions, or briefing documents issued during the period above relating to: employees unable to meet visa salary thresholds handling visa expiry where sponsorship or renewal may not be possible any mitigation measures intended to retain affected staff This may include, but is not limited to: HR guidance manager guidance workforce planning instructions redeployment guidance salary/uplift or role-change mitigation discussions

6) Internal assessments, risk reviews, or communications Please provide copies of any recorded information created or held during the period above relating to the impact of the April 2025 visa salary threshold changes on staffing. This may include: internal impact assessments workforce risk reviews HR reports board, committee, or senior management papers internal emails or briefing notes communications with NHS England, DHSC, UKVI, or the Home Office To help keep this request within cost limits, if necessary this part may be interpreted as limited to: documents or correspondence containing the terms “visa threshold”, “salary threshold”, “Skilled Worker”, “Band 3”, “Health Care Assistant”, “Nursing Assistant”, “sponsorship”, or “right to work” between: HR Recruitment Workforce / People Directorate Executive / senior leadership teams

7) Recording systems Please state whether the Trust has a specific policy, procedure, or system for recording and monitoring employee visa status, visa expiry dates, and sponsorship status. If so, please provide: the name of the policy/procedure/system a copy of the relevant policy, or a summary of the process if a full document cannot be provided Clarification / format

If any part of this request is considered too broad or likely to exceed the appropriate cost limit, please treat this email as a request for advice and assistance under section 16 of the Act, and advise how it may be refined so as to remain answerable.

If any requested information is not held in the exact format requested, please provide any equivalent recorded information that would assist in understanding the scale of the issue. I would prefer to receive the response in electronic format.

Yours faithfully

RLDatix systems and contracts

Contracts, ESR/Workforce

Dear FOI Team,
I am writing to request information under the Freedom of Information Act regarding the Trust’s use of RLDatix systems and associated contracts.
Specifically, I would be grateful if you could provide the following details:
• Which supplier(s) the Trust is currently using for rostering and related workforce systems
• Which RLDatix products or modules the Trust is using (if applicable)
• For each of the following RLDatix products, please indicate whether the Trust uses them (Y/N):
1. Optima
2. Loop
3. SafeCare
4. Datix Cloud IQ (DCIQ)
5. BankStaff / BankStaff+
6. ESR Go
• The annual contract value for these products
• The cost of implementation, including any one off or setup fees
• Any associated hosting costs, including cloud hosting, on premise hosting, or third party hosting arrangements
• The contract end date, including whether any extension options are available within the agreement
If any of the requested information is exempt from disclosure, please provide the relevant exemption and the reasoning behind its application.
Many thanks for your help,

Outsourced Letter Transcription

, would you be able to answer the following questions please:
1. Please can you provide cost information on outsourced letter transcription for the last 3 years?
2. Please can you provide the number of letters by month not meeting a turnaround time of 7 days for the last 3 years?
3. Please can you provide the annual number of documents in backlog for the last 3 years?

Kind regards,

Management of Patient Group Directions (PGDs)

Pharmacy, Staffing

Dear Freedom of Information Officer,

I am writing to make a request for information under the Freedom of Information Act 2000, relating to the management of Patient Group Directions (PGDs) within your organisation.

1. Does your organisation currently use Patient Group Directions (PGDs) to authorise the supply or administration of medicines by registered healthcare professionals?

2. Indicate in the table below approximately how many active, approved PGDs your organisation currently holds?
Number Range Indicate with a cross
<20 20-50 50-100 100-300 >300

3. If known, how many registered healthcare professionals are currently authorised to work under one or more PGDs within your organisation? Please indicate if this information is not held centrally.

4. What system or process does your organisation currently use to manage PGD governance?
a. Paper-based documentation and manual registers
b. Generic document management software (e.g. SharePoint, shared network drives)
c. A dedicated PGD management software system — if so, please name the system
d. Other — please describe

5. Please provide the name, job title, and email address of the individual responsible for PGD governance within your organisation. If this is not held centrally, please indicate who would be the most appropriate contact.

6. In the last 12 months, have any PGDs within your organisation expired without a completed review and reauthorisation in place? If so, approximately how many?

I understand that you are required to respond within 20 working days in accordance with the Freedom of Information Act 2000.

Thank you for your assistance.

Yours faithfully,

Seclusion Practices

Copy of Trust Policy

To whomever this concerns,

My name is Eleanor Anderson, and I’m an MSc student studying Clinical and Health Psychology at the University of Manchester. I’m currently conducting a research project as part of my degree, where I am exploring seclusion practices in the NHS.

The data from this request would be used as part of my analysis, and, therefore, would be greatly appreciated.

Please could you send me all the trust policies related to seclusion practices? For example: in what circumstances these practices should be used; how they should be used; staff training; any guidance on ensuring practice is trauma-informed; and how the process is monitored or reviewed.

I would like to make it clear that this request is not for any individualised patient data.

Please be assured that your Trust’s name will be anonymised as part of my analysis.

Kind regards,

Urgent & Emergency Services Provided – Young people who Self Harm

To whom it may concern,

This is a request under the Freedom of Information Act 2000.

I am seeking information about urgent and emergency services provided by your organisation for young people following self-harm.

Please could you provide the following information?

1. A list of all services/pilots/programmes provided by your organisation that offer support, assessment or intervention to young people (aged 25 years or under) within 24 hours of a self-harm episode (defined according to NICE 2022: intentional self-poisoning or injury, irrespective of the apparent purpose).

2. For each service identified, please provide (where available):

a. Service name
b. Brief description of the service (e.g., aim and objectives)
c. Eligibility criteria (including age)
d. Access routes (e.g., telephone, walk-in service, referral from A & E/GP)
e. Service setting (e.g., online, community-based, hospital-based)
f. Availability (days and hours of operation) g. Geographic area covered

I am specifically interested in services that respond within 24 hours of a self-harm episode, instead of longer-term or routine care (eligible services may include crisis teams, liaison psychiatry services, safe havens, crisis cafes, helplines and other urgent mental health support services). For the avoidance of doubt,

I am looking for any services for individuals aged 25 years or under, including both specialist children/young people’s services and services primarily designed for adults that may also be accessed by this age group.

Thank you in advance for your time and assistance.

Kind regards

Patient Bedside Entertainment Systems

Dear Freedom of Information Team,

Please provide the following information under the Freedom of Information Act 2000 in relation to patient bedside entertainment and engagement systems within your Trust.

Where possible, please provide the most recent available information.

1. Bed Capacity

a) What is the total number of inpatient beds across the Trust?

2. Bedside Entertainment Provision

a) How many inpatient beds are equipped with bedside entertainment systems?
b) If possible, please indicate the approximate proportion of total beds this represents.

3. Provider Information

a) Who is the current provider (or providers) of bedside entertainment services?
b) If services vary by site or ward, please provide details where available.

4. Contract Details

a) What is the start date of the current contract(s)?
b) What is the end or renewal date of the contract(s)?
c) If applicable, what is the total contract value or annual cost?

5. Patient Access via Personal Devices (BYOD)

a) Does the Trust provide access to entertainment or digital services via patients’ personal devices?
b) If yes, please briefly describe the services available.

6. Services Offered

a) What services are provided through bedside systems (e.g.
television, radio, internet access, patient education, communication tools)?
b) Please indicate which of these are currently active.

7. Usage and Engagement

a) Does the Trust collect usage or engagement data for these systems?
b) If yes, please provide any available summary metrics (e.g. number of users, sessions, or usage rates).

8. Patient Feedback

a) Does the Trust collect patient satisfaction or feedback relating to bedside entertainment systems?
b) If yes, please provide any available summaries or key findings.

9. Support Model

a) Is the bedside entertainment system supported internally or by an external provider?
b) If externally supported, please confirm the provider responsible.

If any part of this request exceeds cost limits, please provide the information up to the limit and advise how the request may be refined.

If the information is already publicly available, please provide a link.

Please provide the response in electronic format.

IT Infrastructure, Digital Maturity and Technology Contracts

Corporate Governance, Finance, IT, Procurement, Staffing

Dear Freedom of Information Team,

I am writing to make a request under the Freedom of Information Act
2000 as part of my data collection efforts for personal educational studies. Please treat this as a formal request for recorded information held by Gloucestershire Health and Care NHS FT

I am requesting information relating to your organisation’s IT infrastructure, digital maturity, staffing, contracts and technology spend. To assist in processing this request efficiently, I have structured it into clearly numbered sections below.

──────────────────────────────────────
SECTION 1 — IT BUDGET AND SPEND
──────────────────────────────────────

1.1 What is your organisation’s total annual IT / digital technology budget for the current financial year (or most recently completed financial year)? Please break this down into:
(a) Capital expenditure (CapEx)
(b) Operational expenditure (OpEx)

1.2 What proportion of your total organisational budget does IT / digital technology represent (as a percentage)?

1.3 Is there a separate cyber security budget? If so, what is its value?

1.4 Please provide the name(s) of any Commissioning Support Units
(CSUs) or managed service partners that manage IT expenditure on your behalf, if applicable.

──────────────────────────────────────
SECTION 2 — IT STAFFING
──────────────────────────────────────

2.1 How many whole-time equivalent (WTE) staff are directly employed in IT, digital or technology roles within your organisation?

2.2 Please provide a breakdown of IT staff by job role or band (e.g.
Agenda for Change band or equivalent). Specific names are not required.

2.3 Does your organisation have the following named roles in post?
(Please answer Yes / No / Vacant for each):
(a) Chief Information Officer (CIO) or equivalent
(b) Chief Digital Officer (CDO) or equivalent
(c) Chief Technology Officer (CTO) or equivalent
(d) Chief Information Security Officer (CISO) or equivalent
(e) IT Director / Head of IT
(f) Digital Transformation Lead or equivalent

2.4 How many IT staff are employed via third-party contractors or agency arrangements? What is the approximate annual spend on these arrangements?

──────────────────────────────────────
SECTION 3 — SERVER AND COMPUTE INFRASTRUCTURE ──────────────────────────────────────

3.1 Does your organisation operate on-premise server infrastructure? If yes:
(a) What is the approximate number of physical servers in operation?
(b) What server vendors / manufacturers does your organisation use (e.g. Dell, HPE, Lenovo, Cisco UCS)?
(c) What is the approximate age profile of your server estate (e.g. percentage under 3 years, 3–5 years, over 5 years old)?

3.2 Does your organisation use virtualisation technologies? If yes, which platform(s) (e.g. VMware, Microsoft Hyper-V, Nutanix)?

3.3 Does your organisation use hyperconverged infrastructure (HCI)?
If yes, which vendor(s)?

3.4 Does your organisation use cloud computing services (not including office 365)? If yes:
(a) Which cloud provider(s) do you use (e.g. AWS, Microsoft Azure, Google Cloud, other)?
(b) Approximately what proportion of your workloads are cloud-hosted vs on-premise?
(c) What is the approximate annual cloud spend?

──────────────────────────────────────
SECTION 4 — STORAGE INFRASTRUCTURE
──────────────────────────────────────

4.1 What storage platform(s) does your organisation use (e.g. NetApp, Dell EMC, Pure Storage, HPE, IBM)?

4.2 What is the approximate total usable storage capacity across your estate (in TB or PB)?

4.3 What is the approximate age of your primary storage estate?

──────────────────────────────────────
SECTION 5 — BACKUP, DISASTER RECOVERY AND BUSINESS CONTINUITY ──────────────────────────────────────

5.1 What backup software solution(s) does your organisation currently use (e.g. Veeam, Commvault, Veritas NetBackup, Cohesity, Rubrik, Zerto)?

5.2 What is your backup target infrastructure (e.g. on-premise disk, tape, cloud)?

5.3 Does your organisation have a documented Disaster Recovery (DR) plan? When was it last tested?

5.4 What is the current Recovery Point Objective (RPO) and Recovery Time Objective (RTO) for your critical clinical systems?

5.5 Does your organisation use an offsite or cloud-based backup solution? If yes, which provider?

──────────────────────────────────────
SECTION 6 — NETWORKING AND END-USER COMPUTING ──────────────────────────────────────

6.1 Who provides your Wide Area Network (WAN) and/or internet connectivity services?

6.2 What network equipment vendors does your organisation use (e.g.
Cisco, Juniper, Aruba, Palo Alto)?

6.3 What is the approximate number of end-user devices (laptops, desktops, tablets) in your organisation?

──────────────────────────────────────
SECTION 7 — SOFTWARE, LICENSING AND KEY CLINICAL SYSTEMS ──────────────────────────────────────

7.1 What is your current Electronic Patient Record (EPR) / Electronic Health Record (EHR) system? Please provide the vendor name and product.

7.2 What Patient Administration System (PAS) does your organisation use?

7.3 Does your organisation use a Picture Archiving and Communication System (PACS) / radiology imaging system? If yes, which vendor and product?

7.4 Does your organisation have a Microsoft Enterprise Agreement (or
equivalent) in place? When is this due for renewal?

7.5 What is the approximate annual spend on software licences across the organisation?

7.6 Please list any other significant enterprise IT contracts (by contract type / system category — e.g. HR, finance, workforce
management) with approximate annual values where held.

──────────────────────────────────────
SECTION 8 — WARRANTIES, CONTRACTS AND PROCUREMENT ──────────────────────────────────────

8.1 For your primary server, storage and network infrastructure, are vendor warranties and/or third-party maintenance contracts in place?
Please provide:
(a) The type of coverage (vendor warranty, third-party maintenance, or both)
(b) The name of the maintenance provider(s), if applicable
(c) Approximate contract expiry dates where held

8.2 What procurement frameworks does your organisation use for IT hardware and services (e.g. Crown Commercial Service, NHS Shared Business Services, G-Cloud, Tech Products 4)?

8.3 Are any significant IT contracts due for renewal within the next
24 months? Please provide contract category (not necessarily full commercial detail).

──────────────────────────────────────
SECTION 9 — DIGITAL MATURITY AND STRATEGY ──────────────────────────────────────

9.1 Has your organisation completed a Digital Maturity Assessment
(DMA) or equivalent framework in the last two years? If so:
(a) Which assessment framework was used (e.g. NHS England DMA, HIMSS EMRAM, Other)?
(b) What overall maturity score or rating was achieved?

9.2 Does your organisation have a current Digital / IT Strategy? If so, what is the publication or approval date?

9.3 Has your organisation achieved or is actively working towards any recognised digital accreditations (e.g. HIMSS Level, NHS Digital aspirant status, Cyber Essentials Plus)?

9.4 What are the top three stated digital priorities for your organisation in the current or next financial year?

──────────────────────────────────────
FORMAT AND CLARIFICATION
──────────────────────────────────────

I would be grateful to receive the response in electronic format (e.g.
Microsoft Word, PDF or Excel as appropriate). Where information is readily available in an existing published document, a reference or a link to that document would be acceptable.

If you need any clarification about the scope of this request, or if you believe that any element of it would exceed the appropriate limit under Section 12 of the Act, please contact me before the 20-working-day deadline so that I may prioritise or narrow the questions accordingly.

If any information requested is considered exempt, please specify the relevant exemption for each withheld item and confirm whether the public interest test has been considered.

Yours faithfully,

Clinical System

Dear FOI Team,

I am writing to make an open government request for all the information to which I am entitled under the FOI Act 2000.

Please provide information regarding the following system contracts:
1. Ambient Voice Technology (scribing)
2. EPR
3. Health Information Exchange (HIE)
4. Live operational dashboard system
5. Outcomes/performance benchmarking
6. Scheduling
7. Shared Care Record
8. Simple Business Intelligence
9. Transfers of care system
10. Voice recognition

Please enter ‘No System Installed’ or ‘No Department’ under supplier name if your trust does not use the system or have the department:
a) System type –
b) Supplier name –
c) System name –
d) Date installed –
e) Contract expiration –
f) Is this contract annually renewed? – Yes/No
g) Do you currently have plans to replace this system? – Yes/No
h) Procurement framework –
i) Other systems it integrates with? –
j) Total value of contract (£) –
k) Notes (e.g. we are currently out to tender) –

Please provide your answer in the above format for each system.

System definitions:
Ambient Voice Technology (scribing): Ambient Voice Technology (AI Scribe) – Technology that automatically captures and transcribes clinician–patient conversations in real time and uses artificial intelligence to generate structured clinical notes or documentation. This differs from standard speech recognition or dictation tools because the system works in the background during consultations and produces draft notes for clinician review rather than requiring manual dictation.

EPR: An electronic patient/health record is an electronic record of periodic health care of a single individual, provided mainly by one institution. A digital version of a patient’s paper chart.

Health Information Exchange (HIE): Is the electronic transmission of healthcare-related data among medical facilities, health information organizations, and government agencies according to national standards. HIE enables care professionals to view shared records and make more informed decisions for patients.

Live operational dashboard system: Live operational dashboard system-this is a toolset developed to provide clinicians with the relevant and timely information they need to support daily decision making that improve quality of patient care

Outcomes/performance benchmarking: These systems enable a trust to compare their key clinical outcomes indicators, such as mortality, length of stay and readmission rates, with other NHS trusts

Scheduling: Enterprise level systems that are designed to effectively and efficiently allocate resources (staff, equipment, treatment and even data) to patients at the necessary time and place. Systems in this area range from appointment booking, typically for clinic slots, through to far more sophisticated SAP-style resource allocation and scheduling systems.

Shared Care Record: is a digital system that allows different health and care organisations to securely access and share a patient’s health and care information.

Simple Business Intelligence: Simple Business Intelligence- tools that transform raw data into actionable information

Transfers of care system: System used to manage and collect data on patient moving from one care provider to another.

Voice recognition: Identifies and translates spoken words into text. Used to complete tasks or transcribe documents.

Financial Management System (FMS) / ERP solution

Contracts

Dear FOI officer,

I am writing to you to make a request under the Freedom Of Information Act 2000.

Please provide the following information regarding your Financial Management System (FMS) or ERP solution:
1. Do you operate your finance function via a shared service provider or via an in-house system?
2. If shared service, please provide the name of the provider.
3. If in-house, please provide the system name and vendor. – Underlying ERP platform (if known), Core modules in use (e.g. Finance, Procurement, Payroll), Hosting model (Cloud / On-premise / Hybrid)
4. Please provide the contract start date and end date for the current solution.
5. Please outline any available contract extension options and whether they have been exercised.
6. Any known timelines for re-procurement or system transformation

If any of this information is already published please direct me to the relevant publication.

If you could please confirm receipt of this request and acknowledgement that request will be processed and completed within the 20 working days of receipt.

Many thanks

ATTR Referrals

Dear Gloucestershire Health and Care NHS Foundation Trust,

For the most recent three complete calendar years (e.g. 2023, 2024 and 2025), please provide:

1. The number of patients your Trust referred onwards with a suspected or confirmed diagnosis of transthyretin amyloidosis (ATTR).

If possible, please break this down by:

• Year
• Referring specialty (e.g. cardiology, neurology, nephrology)

2. For the same period, please specify:

• The external centre(s) to which patients with suspected or confirmed ATTR amyloidosis were referred (e.g. National Amyloidosis Centre, regional amyloidosis hubs, tertiary cardiology centres).

Where available, please include:

• The number of patients referred to each centre per year.

Yours faithfully,

Use of non-visual patient safety aid (NVPSA)

Dear Gloucestershire Health and Care NHS Foundation Trust,

I am writing to make a request for information under the Freedom of Information Act 2000 regarding the Trust’s use of specific patient monitoring technology.

1. Does the Trust currently use, or have formal plans to trial or implement, a Non-Visual Patient Safety Aid (NVPSA) – for example, Safehinge Primera’s “Project X”, “Smart Ward” or other radar-based motion tracking – within ward bedrooms, Section 136 suites, and/or seclusion rooms?

2. If the response to the above question is ‘yes’, please provide the following information:

2.1. The number of wards, 136 suites, and seclusion rooms where the technology is deployed (please provide ward names and type of ward).

2.2. The current Policy or Standard Operating Procedure (SOP) governing the use of this technology, including details of your consent process.

2.3. The Data Protection Impact Assessment (DPIA).

2.4. The Equality Impact Assessment (EqIA).

2.5. The Clinical Safety Case Report and Clinical Hazard Log (as required by DCB0129/DCB0160 standards). Please also provide a copy of any entries on the Trust’s Organisational Risk Register that relate to “transferred risks” or residual risks identified during the deployment of this technology.

2.6. The contract start and end dates for the current provision.

2.7. Minutes of meetings where the decision to adopt, trial, continue, expand, or cease the use of the technology was made, including the rationale for the decision.

2.8. Copies of patient-facing information, such as posters, leaflets, or privacy notices provided to service users and carers.

2.9. Copies of all staff training materials or presentation slides relating to the use of NVPSA, including details of the Trust’s competency assurance framework, the mandated frequency of refresher training and the compliance rate (percentage of staff on the relevant wards who have completed training).

3. Please provide all recorded information relating to regulatory compliance, including:

3.1. Any internal audit, gap analysis, or briefing paper that demonstrates how the use of NVPSA technology complies with the Care Quality Commission (CQC) published guide on “Digital contactless patient monitoring technologies in mental health in-patient services”.

3.2. Evidence (e.g. a compliance statement or committee minute) showing how the deployment of this monitoring technology aligns with the NHS England’s “Principles for using digital technologies in mental health inpatient treatment and care”.

If you feel a Section 40 (Personal Information) or Section 43 (Commercial Interests) exemption applies to any part of this request, please provide a redacted version of the documents rather than a blanket refusal, and include the required public interest test for any qualified exemptions.

Yours faithfully,

Maternity Claims

RE: Request under the Freedom of Information Act (2000)

Dear Information Team

This is an information request regarding compensation paid for maternity claims.

Please include the following information for the following years 2022/23, 2023/24, 2024/25 and 2025/26

• The total value of compensation claims paid in respect of maternity claims, please include a break down by:
o Claimant costs
o The Trust’s legal costs

• Total number of maternity compensation claims made, broken down by:
o Settled with admission of liability
o Settled without admission of liability
o Failed claims

• Total number of maternity claims currently open or in progress

• A breakdown of the reasons for maternity compensation claims and the number of cases that fell into each category.
o (for example Cerebral palsy and other brain injuries to the baby, stillbirth, neonatal death, other significant injury to the baby, maternal death, significant maternal injury, psychological injury etc)

• For each year please provide the largest maternity compensation claim including information on:
o Total damages paid
o The category of the maternal injury

If you have any queries please don’t hesitate to contact me via email or phone and I will be very happy to clarify what I am asking for.

I would prefer a response via email, but if not possible, I will gladly accept letters to the address below.

Please acknowledge this information request as soon as possible.

Kind regards,

Complex Home Care

ESR/Workforce, What Do They Know

Under the Freedom of Information Act, I would like to request the following information relating to patients requiring complex home care packages on discharge from hospital.

For clarity, “complex home care” refers to high-acuity packages requiring significant care input (e.g. ventilation, tracheostomy care, enteral feeding, or complex neurological support) that goes beyond basic domiciliary home care assistance.

Failing that definition, please define “complex home care” as any home care package eligible for funding under the NHS Continuing Healthcare (CHC) funding pathway.

Please note I have requested a breakdown of the data by age group. If data cannot be broken down by requested age bands, then please provide total figures across all age groups, adults aged 18+ and children aged 0-17.

If data for the full year 2025/26 is not yet available, then please provide the latest yearly snapshot data for 2025/26.

Where possible, please kindly include responses on the attached spreadsheet.

1. Please provide the name, telephone number and email address of the person responsible for coordinating / liaising discharge from hospital to community health and social care providers.

2. For each of the following years (2022/23, 2023/24, 2024/25, and latest 2025/26 data), please provide the total number of bed days lost due to delays in arranging CHC-funded complex home care packages across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

3. Please provide the most recent available snapshot (e.g. March 2026) of the total number of patients currently in hospital who are medically fit for discharge but are awaiting a CHC-funded complex home care package across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

4. If available, please also provide latest equivalent snapshots for prior years (e.g. March 2025, March 2024, March 2023) of the total number of patients currently in hospital who are medically fit for discharge but are awaiting a CHC-funded complex home care package across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

5. For each of the following years (2022/23, 2023/24, 2024/25, and latest 2025/26 data), please provide the average time (in days) from being medically fit for discharge to discharge where a CHC-funded complex home care package is required across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

6. For each of the following years (2022/23, 2023/24, 2024/25, and latest 2025/26 data), please provide the number of patients who were assessed as requiring complex home care but were discharged to an alternative setting (e.g. residential or nursing care) due to a lack of CHC-funded complex home care packages across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years
Kind regards,

Haemophilia A and B and von Willebrand Patients

Health, Pharmacy

Hi FOI team for Gloucestershire Health and Care NHS Foundation Trust,

Under the Freedom of Information (FOI) Act 2000 I would like to obtain the following information:

In Q1 2026 (January, February, March 2026), how many haemophilia A and B and von Willebrand patients were treated with the following coagulation factors in your trust and how much volume (IUs or mg) was used?

Brand name Number of treated patients Volume used (IUs, mg)
Hemlibra (non-inhibitor patients)
Hemgenix
Altuvoct
Advate
Adynovi
Elocta
Esperoct
NovoEight
ReFacto AF
Nuwiq
Hympavzi
Idelvion
Refixia
Alprolix
BeneFIX
Replenine
Rixubis
Veyvondi
Voncento
Wilate
Willfact

Best wishes,

Net Zero Staff and Consultant Spending

ESR/Workforce, Estates, Finance, Staffing

Dear Sir or Madam,

Under the Freedom of Information Act 2000, please provide the following recorded information.

From the financial year 2024/25, 2023/24, and 2022/23 figures:

1. Climate-related posts

a) The number of posts (headcount, and FTE where recorded) employed by the council with job titles that include any of the following terms:

Climate; Net Zero; Sustainability; Carbon; Emissions; Environmental Sustainability; Climate Change; Climate Action; Climate Policy; Climate Programme; Climate Project; Climate Data; Climate Reporting; Climate Adaptation; Climate Resilience; Energy and Climate; Sustainable Procurement; Green Finance; Green.

2. Cost of those posts

The total employment cost for the posts identified in Question 1, including salary and employer on-costs (e.g. pension and National Insurance), as recorded by the council.

3. External consultants

The total amount paid during the same financial year to external consultants, companies, or contractors where the expenditure is recorded under any cost centre, project code, budget line, or purchase description that includes one or more of the following terms:

This should include, but not be limited to, expenditure coded to professional services, consultancy, advisory services, or specialist support.

If the council does not record expenditure in this way, please provide the closest equivalent recorded information held (for example, totals by relevant cost centre or project).

If any information requested is not held, please state this clearly. If figures are held only in aggregated form, please provide the aggregated figures. Estimates derived from recorded financial information are acceptable.

If complying with this request would exceed the cost limit under Section 12 of the Freedom of Information Act, please provide advice and assistance under Section 16 as to how the request may be refined.

Please provide the information requested above in the following table format, where held:
Financial Year
Job Title
Staff Costs including on-costs (£)
Headcount
Consultant Spend

Yours faithfully,

Temporary and Permanent Agency Labour Spend

Dear Gloucestershire Health and Care NHS Foundation Trust,

Please could you provide me with the following information:

-Total Non clinical Temporary agency spend from August 2025 to date. ( including admin and clerical roles, ancillary, IT, corporate functions and scientific, technical and clinical coding )

-Agencies used for non clinical recruitment from August 2025 to date.

-Spend broken down by agency from August 2025 to date.

-Please advise if you use an agency for permanent recruitment.

– What framework you use- such as CCS RM6277 , HTE

Yours faithfully,

Workforce Disability Equality Standard

Corporate Governance, HR

Hi Gloucestershire Health and Care NHS team,

I was reading your Annual Equalities Report 2023–24.

You note that the trust publishes annual Workforce Disability Equality Standard action plans, and your disability action plan says the 2021–26 People Strategy agreed actions to improve disability recruitment.

How do you evidence, at the vacancy level before shortlisting, where each role was promoted and what engagement it generated with disabled candidates and communities you are trying to reach?

Disability Network helps employers build that advert stage record at vacancy level. That gives HR clearer evidence if the role is questioned later.

I can send a short overview if useful.

Kind regards,

Incidents of Sexual Violence

Corporate Governance

Dear Sir,

FOI request: Governance related to sexual offending at the trust

1) Please disclose by each of the following years, the total number each year of incidents of sexual violence (including sexual assault and rape) reported by the trust to the Care Quality Commission:

2021/22
2022/23
2023/24
2024/25
2025/26 YTD

2) If the data is held centrally and can be easily processed within FOIA limits, please advise how many of the incidents of sexual violence in the period April 2021 to 2026 YTD were perpetrated against patients.

3) It has been reported by the media that a patient was raped whilst under the trust’s care in the last financial year.

Please confirm if this is the case.

Please advise if and when the CQC was informed of this serious incident

Please advise:

a) if this incident took place on trust premises
b) whether the patient was under inpatient care
c) if the patient was detained under the Mental Health Act

Please advise what review if any has been undertaken by the trust, and what learning and Safeguarding improvements have been made since the incident.

4) Please advise if the trust undertakes any benchmarking to compare its rates of sexual violence against other comparator trusts, the results of any such benchmarking and any action plans arising.

Yours,

Prostate Specific Antigen/suspected prostate cancer referral thresholds

GHNHSFT - Redirect, What Do They Know

Dear Gloucestershire Health and Care NHS Foundation Trust,

1. Do you have a Urology department who see suspected prostate cancer patients referred from the community?

2. What criteria are used to triage (Accept or Reject) referrals from the community, for patients with suspected prostate cancer, including Prostate Specific Antigen (PSA) thresholds and Digital Rectal Examination (DRE) for asymptomatic patients? Please include specific PSA levels used as well as any other criteria

3. What criteria are used to triage (Accept or Reject) referrals from the community, for patients with suspected prostate cancer, including PSA thresholds and DRE for symptomatic patients? Please include specific PSA levels used as well as any other criteria

4. How does your service define symptomatic and asymptomatic for suspected prostate cancer referrals?

5. Do you apply different thresholds or criteria for higher-risk groups (e.g. Black men, men with family history)?

6. For the calendar year 2025:
a. How many patients were referred on the suspected prostate cancer pathway?
b. Of these, how many were classified by the referrer (or by your triage) as asymptomatic?
c. How many were classified as symptomatic?

7. For the same period, how many referred patients had their 2WW referral rejected? Please break this down, if possible, by:
a) Asymptomatic vs symptomatic
b) Rejected primarily due to PSA level below threshold

8. Please provide a copy of your suspected prostate cancer referral form for both asymptomatic and symptomatic patients?

Yours faithfully,

GLP-1 receptor agonists prior to OGD

Copy of Trust Policy, Health, MH Services

Dear Sir/Madam,

I am writing to request information under the Freedom of Information Act 2000 regarding your Trust’s guidance and practice relating to the management of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) prior to upper gastrointestinal endoscopy (oesophago-gastro-duodenoscopy, OGD).

This request forms part of a national study assessing variation in NHS Trust practice. ⸻

Information Requested

1. Guidance Availability

a) Does your Trust have any guidance, protocol, or policy relating to the management of GLP-1 receptor agonists prior to OGD?

b) If yes, please provide:
• A copy of the guidance, or
• A link to where it is publicly available

2. Medication Management

a) What is your Trust’s recommendation regarding oral GLP-1 receptor agonists prior to OGD? (e.g. continue, omit morning dose, withhold for a defined period)

b) What is your Trust’s recommendation regarding injectable GLP-1 receptor agonists prior to OGD?

3. Indication-Specific Guidance

a) Does your Trust differentiate guidance based on indication (e.g. diabetes vs obesity)?

b) If yes, please outline how recommendations differ.

4. Fasting Protocol

a) Does your Trust modify fasting instructions for patients taking GLP-1 receptor agonists prior to OGD?

b) If yes, please provide details of the modified fasting protocol.

5. Operational Impact

a) Has your Trust identified any impact of GLP-1 receptor agonist use on OGD procedures (e.g. cancellations, retained gastric contents, aspiration risk)?

b) If recorded, please provide any available data or summary information.

6. Governance

a) Has the management of GLP-1 receptor agonists in endoscopy been discussed, reviewed, or audited within your Trust?

Format of Response Please provide the information in electronic format where possible. If any part of this request exceeds cost limits, I would be grateful if you could:

• Advise how the request may be refined

or

• Provide the information that falls within the allowable limit

Clarification

This request relates only to adult elective OGD procedures and excludes colonoscopy or other endoscopic procedures unless included within a shared protocol.

Additional Notes

Where exact data is not held, a summary of local practice or clinical guidance is acceptable.

Thank you for your time and assistance.

I look forward to your response within the statutory 20 working days.

Clinical Risk Assessment & Management and or Suicide Prevention

Hello Gloucestershire Health and Care NHS Trust FOI team,

I am writing to you under the Freedom of Information Act 2000 to request the following information from Gloucestershire Health and Care NHS Trust’s freedom of information department. Please may you provide me with:

1. A copy of your Policie(s)/ procedures, strategies and or any clinical guidance relevant to mental health care pertaining to clinical risk assessment and management and or suicide prevention.
2. Do you use any triage tools, rag rating or scales to stratify clinical risk?
2.1. If Yes, do they inform care in any way including different tiers.
2.2. If Yes please provide a copy.

Please provide the information in the form of word documents or if not possible pdf files.

If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.

If you can identify any ways that my request could be refined, I would be grateful for any further advice and assistance.

If you have any queries please don’t hesitate to contact me via email and I will be very happy to clarify what I am asking for and discuss the request, my details are outlined below.

Thank you for your time and I look forward to your response.

Best wishes,

Clinical Waste Management

Good afternoon
I am a student who is currently researching the clinical waste market in the UK. As part of my research, I have the below questions:
1)Suppliers who applied for inclusion on each Framework / Contract and were successful & not successful at the PQQ & ITT Stages.
2) Actual Spend on this Contract / Framework (and any sub lots), from the start of the Contract to the Current Date.
3) Start Date & Duration of Framework / Contract?
4) Could you please provide a copy of the service / product specification given to all bidders for when this contract was last advertised?
5) Is there an extension clause in the Framework(s) / Contract(s) and, if so, the duration of the extension?
6) Has a decision been made yet on whether the Framework(s) / Contract(s) are being either extended or renewed?
7) Who is the Senior Officer (outside of procurement) responsible for this contract?
8) Who is the Infection Control Lead responsible for the Trust + Contact Information?
9) Who is the Procurement Lead for Clinical Waste contracts for the Trust + Contact Information?
10) Who is the Environmental / Sustainability Lead for the Trust + Contact Information?
11) Who is the Waste Management Lead for the Trust + Contact Information?
12) Who is the Health and Safety Lead for the Trust + Contact Information?
13) Who is the Clinical Waste Incumbent?
14) Does the Trust make use of Reusable or Disposable Sharps Containers?
15) Current waste split between Alternative treatment, Incineration and offensive waste?
Many thanks

Halal Meat – Community Hospitals

Dear Sir or Madam,

I am writing to make a Freedom of Information Request related to the following hospitals operated by your trust:

Gloucestershire Royal Hospital, Cheltenham General Hospital, Charlton Lane, Honeybourne, Laurel House, Wotton Lawn Hospital, Berkeley House, Cirencester Hospital, Dilke Memorial Hospital, Lydney and District Hospital, North Cotswolds Hospital, Stroud General Hospital, Tewkesbury Community Hospital, Vale Community Hospital, Forest of Dean Community Hospital, The Maxwell Centre, and Fairford Hospital.

1. Do any of the hospitals listed above serve ANY HALAL MEAT?
2. If the answer to (1) is “yes”, is it labelled as such?
3. If the answer to (1) is “yes”, what percentage of meat served is Halal?
4. If the answer to (1) is “yes”, who is your supplier?

Please answer all the above within 28 days.

If you are unable to, or need more time, please inform me within 7 days.

I am assuming there will be no charge: if there is, please let me know within 7 days. I think my questions are straightforward, but if you do not understand the questions, please inform me within 7 days.

Yours faithfully,

Infection Prevention & Control (IPC) – GRHNHSFT

Dear FOI Team,
Please treat this as a request for information under the Freedom of Information Act 2000.
I would be grateful if you could provide the following information regarding the Infection Prevention & Control (IPC) leadership and IPC nursing team at Gloucestershire Hospitals NHS Foundation Trust, covering:
• Gloucestershire Royal Hospital
• Cheltenham General Hospital
• Any associated services delivered by the Trust
1. IPC Leadership – Names, Roles, and Contact Details
Please provide the name, job title, and NHS email address (where publicly releasable) for the following positions:
• Director of Infection Prevention & Control (DIPC)
• Deputy DIPC
• Lead Nurse for Infection Prevention & Control
• IPC Matron / IPC Manager
• Infection Prevention & Control Doctor (IPCD)
• Any Consultant Microbiologists with designated IPC responsibility
2. IPC Nursing Team
For all IPC nursing staff employed by the Trust, please provide:
• Names
• Job titles and bandings
• NHS email addresses (where publicly releasable)
• The clinical areas or sites they cover
3. IPC Organisational Structure
Please provide:
• The most recent IPC organisational structure chart, including reporting lines
• Any documentation describing how IPC services are structured across the Trust
4. IPC Contact Information
Please provide:
• Any generic IPC team email addresses
• Any team telephone numbers used for clinical enquiries or staff contact
• Any site specific IPC contact details, if applicable
5. Additional IPC Documentation
If available, please provide:
• The most recent IPC Annual Report
• Any IPC governance documents or summaries produced within the last 12 months
If any part of this request is unclear or likely to exceed the appropriate cost limit, please let me know so I may refine it. I am happy to receive the information electronically.

Artificial Intelligence (AI)

Corporate Governance, IT

Dear Sir or Madam,

I am writing to request information under the Freedom of Information Act 2000. This request concerns your organisation’s strategy, governance, and use of artificial intelligence (AI).

For the purposes of this request, artificial intelligence refers to software or systems that perform tasks normally requiring human intelligence, including machine learning, computer vision, natural language processing, and predictive analytics.
I would be grateful if you could provide the answers to the relevant questions by completing the table attached at the end of this request.

1. AI leadership – Does the trust have named leaders for clinical AI tool evaluation and implementation? If so, please provide their names, NHS job titles and NHS email addresses?
2. AI Strategy and Planning – Does the trust have an artificial intelligence (AI) strategy, roadmap, or equivalent strategic document? If yes, please provide a copy or link.
3. AI Policies – Does the trust have approved policies specific to the development, procurement, or use of AI tools? If yes, please provide copies.
4. Governance and Oversight – Does the trust have a dedicated governance committee or formal mechanism reviewing AI initiatives for ethical and safety considerations? If yes, does it include clinical representation?
5. Use of AI in Clinical Care – Is the trust currently using AI tools in clinical care? If yes, does the trust conduct regular audits and use standardised methodologies (e.g. dashboards) to assess financial, clinical, and operational impact?
6. AI Literacy and Training – Does the trust offer AI literacy or skills training for the following staff groups? Please indicate yes/no and provide brief details.

(a) Clinical staff
(b) Technical staff (e.g. clinical scientists)
(c) Operational staff (e.g. secretaries, MDT coordinators and managers).

NHS Trust Name Please confirm the name of the NHS trust

Name(s) of AI evaluation and implementation lead(s) Please add (separate by a “;”/semicolon if more than one lead)

Job title(s) of AI evaluation and implementation lead(s) Please add (separate by a “;”/semicolon if more than one lead)

Email address(es) of AI evaluation and implementation lead(s) Please add (separate by a “;”/semicolon if more than one lead)

Q2: Local AI Strategy Yes/No (delete as appropriate)
Q3: Local AI Policies Yes/No (delete as appropriate)
Q4a: Local governance Yes/No (delete as appropriate)
Q4b: Clinical representation for AI governanceGovernanceClinical Yes/No/Not applicable (delete as appropriate)
Q5: Current AI use Yes/No (delete as appropriate)
Q5b: AI use audit Yes/No/Not applicable (delete as appropriate)
Q5c: AI use impact assessment Yes/No/Not applicable (delete as appropriate)
Q6a: AI training for clinical staff Yes/No (delete as appropriate)
Q6b: AI training for clinical staff Yes/No (delete as appropriate)
Q6c: AI training for operational staff Yes/No (delete as appropriate)

If any part of this request exceeds the cost limit under Section 12 of the Act, please advise which elements could be refined.

If the information is not held, please confirm this.

Thank you very much for your help.

Yours faithfully,

Digital Mental Health